B cells are critical to t-cell–mediated antitumor immunity induced by a combined immune-stimulatory/ conditionally cytotoxic therapy for glioblastoma | ||
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | Biogen Idec | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences | |
| dc.conicet.organizacion | University of California at Los Angeles | |
| dc.conicet.organizacion | University of Michigan | |
| dc.contributor.author | Candolfi, Marianela | |
| dc.contributor.author | Curtin, James F. | |
| dc.contributor.author | Yagiz, Kader | |
| dc.contributor.author | Assi, Hikmat | |
| dc.contributor.author | Wibowo, Mia K. | |
| dc.contributor.author | Alzadeh, Gabrielle E. | |
| dc.contributor.author | Foulad, David | |
| dc.contributor.author | Muhammad, AKM G. | |
| dc.contributor.author | Salehi, Sofia | |
| dc.contributor.author | Keech, Naomi | |
| dc.contributor.author | Puntel, Mariana | |
| dc.contributor.author | Liu, Chunyan | |
| dc.contributor.author | Sanderson, Nicholas R. | |
| dc.contributor.author | Kroeger, Kurt | |
| dc.contributor.author | Dunn, Robert | |
| dc.contributor.author | Martins, Gislaine | |
| dc.contributor.author | Castro | |
| dc.contributor.author | Lowenstein, Pedro R. | |
| dc.contributor.author | Castro, Maria G | |
| dc.date.issued | 2011-10 | |
| dc.description.abstract | We have demonstrated that modifying the tumor microenvironment through intratumoral administration of adenoviral vectors (Ad) encoding the conditional cytotoxic molecule, i.e., HSV1-TK and the immune-stimulatory cytokine, i.e., fms-like tyrosine kinase 3 ligand (Flt3L) leads to T-cell-dependent tumor regression in rodent models of glioblastoma. We investigated the role of B cells during immune-mediated glioblastoma multiforme regression. Although treatment with Ad-TK+Ad-Flt3L induced tumor regression in 60% of wild-type (WT) mice, it completely failed in B-cell-deficient Igh6-/- mice. Tumor-specific T-cell precursors were detected in Ad-TK+Ad-Flt3L-treated WT mice but not in Igh6-/- mice. The treatment also failed in WT mice depleted of total B cells or marginal zone B cells. Because we could not detect circulating antibodies against tumor cells and the treatment was equally efficient in WT mice and in mice with B-cell-specific deletion of Prdm 1 (encoding Blimp-1), in which B cells are present but unable to fully differentiate into antibody-secreting plasma cells, tumor regression in this model is not dependent on B cells’ production of tumor antigen-specific immunoglobulins. Instead, B cells seem to play a role as antigen-presenting cells (APCs). Treatment with Ad-TK+Ad-Flt3L led to an increase in the number of B cells in the cervical lymph nodes, which stimulated the proliferation of syngeneic T cells and induced clonal expansion of antitumor T cells. Our data show that B cells act as APCs, playing a critical role in clonal expansion of tumor antigen-specific T cells and brain tumor regression. | es |
| dc.description.fil | Fil: Candolfi, Marianela. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina | |
| dc.description.fil | Fil: Curtin, James F.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Yagiz, Kader. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Assi, Hikmat. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Wibowo, Mia K.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Alzadeh, Gabrielle E.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Foulad, David. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Muhammad, AKM G.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Salehi, Sofia. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Keech, Naomi. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Puntel, Mariana. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Liu, Chunyan. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Sanderson, Nicholas R.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Kroeger, Kurt. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos | |
| dc.description.fil | Fil: Dunn, Robert. Biogen Idec; Estados Unidos | |
| dc.description.fil | Fil: Martins, Gislaine. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos | |
| dc.description.fil | Fil: Castro. Cedars Sinai Medical Center. Gene Therapeutics Research Institute; Estados Unidos | |
| dc.description.fil | Fil: Lowenstein, Pedro R.. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Castro, Maria G. Cedars Sinai Medical Center. Gene Therapeutics Research Institute. Department Of Biomedical Sciences; Estados Unidos. University of California at Los Angeles; Estados Unidos. University of Michigan; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Candolfi, Marianela; Curtin, James F.; Yagiz, Kader; Assi, Hikmat; Wibowo, Mia K.; et al.; B cells are critical to t-cell–mediated antitumor immunity induced by a combined immune-stimulatory/ conditionally cytotoxic therapy for glioblastoma; Elsevier Inc; Neoplasia; 13; 10; 10-2011; 947-960 | es |
| dc.identifier.issn | 1522-8002 | |
| dc.identifier.uri | http://hdl.handle.net/11336/15348 | |
| dc.journal.number | 10 | es |
| dc.journal.pagination | 947-960 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Neoplasia | es |
| dc.journal.volume | 13 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1593/neo.11024 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1476558611800825 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201571/ | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | es |
| dc.subject | Adenovirus Gene Therapy | es |
| dc.subject | Hsv1 Thymidine Kinase +Flt3l | es |
| dc.subject | B Cells | es |
| dc.subject | Glioblastoma | es |
| dc.subject.classification | Otros Tópicos Biológicos | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | B cells are critical to t-cell–mediated antitumor immunity induced by a combined immune-stimulatory/ conditionally cytotoxic therapy for glioblastoma | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.18440.pdf
- Tamaño:
- 2.75 MB
- Formato:
- Adobe Portable Document Format